๐ฐ Geisel School News
Page 22 - Geisel School News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Geisel School. Real-time updates on events, politics, business and more.
January 25, 2023
While the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) recommend ...
January 24, 2023
System Designed to Reduce the Incidence of Positive Margins or Cancer Left Behind After Breast Cancer Surgery CairnSurgical, Inc., an innovator striving to make breast cancer surgery more precise
January 20, 2023
Findings from a new study published in The Clinical Journal of the American Society of Nephrology, involving a collaborative effort between researchers at Dartmouth's Geisel School of Medicine, Vanderbilt, and Veteran's Affairs (VA) medical centers, show that an implementation science approach using team-based coaching and automated surveillance reporting significantly improves the risk of acquiring post-procedural acute kidney injury (AKI) when compared to other interventions.
January 19, 2023
Sayarath, who researched nutrition and health in New England and enjoyed both photography and creative writing, died at age 61 in November.
January 18, 2023
COVID-19 is changing household behaviors related to how we are exposed to various household chemicals linked to poor health outcomes.
January 18, 2023
COVID-19 is changing household behaviors related to how we are exposed to various household chemicals linked to poor health outcomes.
January 15, 2023
It isnโt that there arenโt racial justice issues to tackle in Claremont. Itโs that, as a member of the cityโs School Board, Whitney Skillen is looking at the bigger picture.Elected as a write-in candidate 10 months ago, Skillen campaigned by talking...
January 13, 2023
As energy prices skyrocket throughout the Upper Valley, Dartmouth graduate students struggle to stay warm.
January 6, 2023
We know that more than 70% of individuals who survive a suicide attempt will never attempt suicide again. Those with access to firearms, due to their intrinsic lethality, unfortunately will not have a second chance.
January 4, 2023
/PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious disease...